Ledger.Open graph →
SEC Form D · filed June 11, 2010

IRX Therapeutics, Inc

Offering
—
Sold
$8.0M
Exemption
—
Industry
Biotechnology
Location
New York, NY
Type
—

People & firms on this filing (9)

John W. Hadden · New York, NYDirectorDale S. Okonow · Lexington, MADirectorEric Strasser · San Francisco, CADirectorJohn N. Spencer, Jr · Memphis, TNExecJohn C. Pernell, Jr · Johns Island, SCExecJohn T. Spitznagel · New York, NYDirectorDonald Kelly · DALLAS, TXDirectorHoward H. Stevenson · New York, NYDirectorFrank J. Loverro · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗